Moving Foward With Myeloma (MFM)
Part of paid clinical trials in Maywood, Illinois.
- Sponsor
- Medical College of Wisconsin
- Study ID
- NCT07236502
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Multiple Myeloma (MM)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Immediate intervention — BEHAVIORAL16-session intervention that facilitates changes in nutrition and physical activity behaviors to promote improvements in physical function, Patient Reported Outcomes, body composition and general health
- Waitlist — OTHERParticipants will be asked to maintain their behavior over the 16 week waitlist period and will receive weekly text message relating positive messages unrelated to lifestyle
Study Details
The purpose of this project is to evaluate the impact of a 16-week lifestyle program that promotes changes in eating and exercise patterns. The main questions the study will answer are: Do improvements in eating and exercise patterns lead to improved physical function, quality of life and blood biomarkers of biologial aging among individuals with multiple myeloma? Participants will complete study activities 3-4 times during the study. 1. In-person assessment to measure physical function, height/weight, body composition, and includes a blood draw 2. Surveys completed online or on paper at home
Key Dates
- Start date
- Jan 30, 2026
- Status verified
- Jan 2026
- Primary completion
- Dec 15, 2029
- Completion
- Feb 28, 2030
Study Design
- Enrollment
- 184 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Immediate Intervention16-session intervention that facilitates changes in nutrition and physical activity behaviors to promote improvements in physical function, Patient Reported Outcomes, body composition and general health. The intervention targets plant-based eating, increasing physical activity and strength training.
- Active Comparator: Waitlist controlParticipants will be asked to maintain their behavior over the 16 week waitlist period and will receive weekly text message relating positive messages unrelated to lifestyle.
Primary Outcome Measure
Examine the efficacy of the intervention in producing post-intervention changes in performance-based physical function [ Time Frame: Baseline, Week 16, Week 32, Week 48 ]
Central Contacts
- Melinda Stolley, PhD(312)735-6044
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Loyola University Chicago | Maywood | Illinois | 60153 | Patricia Sheean, PhD (PRINCIPAL_INVESTIGATOR) |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 |
Find similar trials in Maywood, IL
Related Studies
- Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple MyelomaPHASE2 · Recruiting · SCRI Development Innovations, LLC · Birmingham, Alabama
- A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma SubjectsPHASE1 · Recruiting · C4 Therapeutics, Inc. · Gilbert, Arizona
- MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple MyelomaPHASE2 · Not Yet Recruiting · University of Arkansas · Little Rock, Arkansas
- A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple MyelomaPHASE1 · Recruiting · Shanghai Henlius Biotech · Springdale, Arkansas